Panagora Asset Management Inc Seres Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $43,928 - $90,367	12,551 Added 8.12%	167,089 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $198,015 - $558,843	73,339 Added 90.32%	154,538 $530,000
Q4 2021 Feb 10, 2022	BUY	$6.02 - $11.43 $488,817 - $928,104	81,199 New	81,199 $676,000
Q2 2021 Aug 11, 2021	SELL	$18.46 - $24.36 $977,087 - $1.29 Million	-52,930 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$17.66 - $28.92 $930,823 - $1.52 Million	52,708 Added 23742.34%	52,930 $1.09 Million
Q4 2020 Feb 10, 2021	BUY	$23.25 - $37.73 $5,161 - $8,376	222 New	222 $5,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.